Agustin Melian - Jul 11, 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role: EVP, Research & Development
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol: FMTX
Transactions as of: Jul 11, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/12/2022, 04:24 PM
Previous filing: Oct 5, 2021
Next filing: Oct 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Award	$0	+79K		$0.00	79K	Jul 11, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FMTX	Stock Option (Right to Buy)	Award	$0	+118K		$0.00	118K	Jul 11, 2022	Common Stock	118K	$8.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2	25% of the shares subject to the stock option shall vest on July 11, 2023, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter.